✨ Free AI Report
Advanced Accelerator Applications: Key Facts, Business Model & Financial Analysis Read the overview below or get the full interactive report with Cyborg Score, analyst debate audio & saved-company playlists — free, no credit card.
Get Free Report →
Home Company Research Advanced Accelerator Applications
Company Research

Advanced Accelerator Applications: Business Overview, Financials & Competitive Analysis

Advanced Accelerator Applications scores 7/10 on the AskCyborg Cyborg Score (Strong). Leading radiopharmaceutical platform with blockbuster oncology therapy, but now narrowed to radiotherapeutics following recent diagnostic arm divestiture. The company owns Lutathera, a first-in-class radioligand therapy product for neuroendocrine tumors. In January 2024, AAA announced plans to expand manufacturing in Japan and China. However, the May 2026 divestiture of its.

What is Advanced Accelerator Applications's industry? Advanced Accelerator Applications (adacap.com) operates in Diagnostic Imaging Equipment. AskCyborg classifies Advanced Accelerator Applications under Diagnostic Imaging Equipment in its company registry.

Advanced Accelerator Applications is a France-based pharmaceutical group specialized in nuclear medicine, operating across PET, SPECT, and therapy segments to diagnose and treat conditions in oncology, neurology, card...

7/ 10Strong

Cyborg Score thesis

Leading radiopharmaceutical platform with blockbuster oncology therapy, but now narrowed to radiotherapeutics following recent...

Read the full analyst-debate transcript →
Industry Diagnostic Imaging Equipment
2 named competitors
2 recent developments
11 analyst dimensions
Synthesized from analyst-debate stress-testing across 11 dimensions and hundreds of data points. Methodology →
Cyborg Score recalibrated: September 21, 2026
AI-Verified Research
30+ Page Report

Get the Latest Advanced Accelerator Applications Report

Up-to-date AI-powered research, analyst debate audio & saved-company playlists

Get Current Report Free
✓ No credit card required
or get it by email

Analyst-debate audio for Advanced Accelerator Applications

AskCyborg analysts argue the bull and bear cases for Advanced Accelerator Applications across 11 stress-tested dimensions. Listen on your commute -- faster than reading the 30-page report.

Play the free intro →
Free intro · Pro unlocks the full analyst debate
What's in This Report
Advanced Accelerator Applications OverviewStrategic ProfileCompetitive LandscapeIndustry ContextKey facts
Get Interactive Report Freeor start reading below

Advanced Accelerator Applications Overview

Pro stress-test →

Advanced Accelerator Applications is a France-based pharmaceutical group specialized in nuclear medicine, operating across PET, SPECT, and therapy segments to diagnose and treat conditions in oncology, neurology, cardiology, and infectious/inflammatory diseases. Novartis acquired the company for $3.9 billion in January 2018.

Strategic Profile

Pro stress-test →

The company's portfolio includes Lutathera (lutetium Lu 177 dotatate), a first-in-class radioligand therapy for neuroendocrine tumors, along with diagnostic products including NETSPOT and SOMAKIT. In May 2026, Siemens Healthineers agreed to acquire AAA's diagnostic arm for €200 million, leaving Novartis with only the radiotherapeutics operations.

Competitive Landscape

Pro stress-test →

AAA is an established leader in molecular nuclear diagnostic radiopharmaceuticals for PET and SPECT, mainly used in clinical oncology, cardiology and neurology. The company competes in the emerging radiopharmaceutical therapeutics space with limited direct competitors, though the May 2026 diagnostic divestiture narrows its competitive scope to radioligand therapy.

Industry Context

Advanced Accelerator Applications operates in Diagnostic Imaging Equipment.

Key facts

Founded: 2002 · Headquarters: Saint-Genis-Pouilly, FR · Employees: N/A · Revenue: N/A · Market cap: N/A

What the analysts stress-tested

The top findings that survived the multi-agent debate for Advanced Accelerator Applications.

  • Focused radiopharmaceutical platform with proven clinical efficacy in neuroendocrine tumors
  • Recent diagnostic divestiture (May 2026) streamlines operations to radiotherapeutics core
+2 more stress-tested counter-arguments unlock with Pro. Read the full analyst debate →

Recent developments

Material events tracked by the AskCyborg corpus.

  • January 2024Announced expansion of manufacturing capabilities in Sasayama, Japan and Haiyan, China
  • May 2026Siemens Healthineers acquired diagnostic arm for €200 million
Get alerted when Advanced Accelerator Applications has a new material development →

Named competitors

Pulled from the analyst-debate framework. Click any competitor to see their Cyborg Score.

RadiogelRadiopharmaceutical therapeutic solutions→PluvictoRadioligand therapy for prostate cancer→

Compare Advanced Accelerator Applications with another company

Pick any company in the AskCyborg corpus to see side-by-side Cyborg Scores and insights.

vs
Side-by-side opens in your AskCyborg account

Industry context

Advanced Accelerator Applications operates in Diagnostic Imaging Equipment. See how the rest of the sector scores on the Cyborg framework.

Browse Diagnostic Imaging Equipment research →
NEW · MCP server

Ask your AI assistant about Advanced Accelerator Applications

Install the free AskCyborg MCP server in Claude, Cursor, Cline, Continue, or Windsurf and ask any of these in-line:

“Compare Advanced Accelerator Applications and its top competitor on Cyborg Score”
“What did Advanced Accelerator Applications do this quarter?”
“Is Advanced Accelerator Applications a defensible business in 5 years?”
Install the MCP server (10 sec) →
Free, anonymous, no API key required

How AskCyborg builds confidence

⚔

Analyst debate, not single-author opinion

Every report is stress-tested by a panel of AI analysts arguing across 11 dimensions. The output is the part of the case that survived pushback.

📊

Recalibrated weekly

The Cyborg Score is recomputed weekly against fresh data. Recent material developments are continuously tracked and surfaced.

🔗

Methodology open at /methodology

The framework, dimensions, and band breakdowns are documented. The same company gets the same score from any analyst running the framework.

🔒

Free tier is free

No credit card to read the research. Pro adds saved-company audio playlists, monitoring, audio briefings on demand, and PDF export for $39/mo annual.

Sources: public filings, regulatory data, news flow, and proprietary analyst signals. Read the methodology →

Frequently asked questions

What does Advanced Accelerator Applications do?+
Advanced Accelerator Applications is a France-based pharmaceutical group specialized in nuclear medicine, operating across PET, SPECT, and therapy segments to diagnose and treat conditions in oncology, neurology, card...
What is Advanced Accelerator Applications's Cyborg Score?+
Advanced Accelerator Applications has a Cyborg Score of 7/10 (Strong). The score synthesizes business model, financials, leadership, competitive position, technology, marketing, and ESG dimensions across hundreds of data points.
Who are Advanced Accelerator Applications's main competitors?+
Named competitors include Radiogel, Pluvicto. The full competitive landscape is in the AskCyborg report.
How can I get the full Advanced Accelerator Applications research report?+
Get the report plus analyst-debate audio at askcyborg.com -- no credit card required for preview access. Pro adds saved-company audio playlists and monitoring.
How current is the Advanced Accelerator Applications research?+
The Cyborg Score is recalibrated weekly. Recent developments are tracked continuously and surfaced in every report.

Track Advanced Accelerator Applications over time

Pro members get saved-company audio playlists, Cyborg Score recalibrations, and monitoring for material events across the AskCyborg corpus.

See Pro features
From $39/mo annual

Top-scored companies on AskCyborg

The strongest performers across the analyst-debate framework.

9Advantest Corporation9Anthropic9Apple Inc.9Applied Materials, Inc.9Arista Networks9Aritzia Inc.9ASML Holding N.V.9BAE Systems plc9Barrick Mining Corporation9Berkshire Hathaway Inc.